Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Breast Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Breast Cancer Drugsmarket, defines the market attractiveness level of Breast Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Breast Cancer Drugs industry, describes the types of Breast Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Breast Cancer Drugs market and the development prospects and opportunities of Breast Cancer Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Breast Cancer Drugs market in Chapter 13.
By Player:
Dr Reddy's Laboratories
Puma Biotech
Celltrion Inc
Mylan
Roche Group
Merck Sharp & Dohme Corp
Verzenio (Eli Lilly)
GlaxoSmithKline
Biocon
Novartis
Pfizer
Bristol-Myers Squibb
AstraZeneca
HALAVEN (Eisai Inc)
By Type:
HER2 Inhibitors
Mitotic Inhibitors
Anti-Metabolites
Aromatase Inhibitors
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Breast Cancer Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Breast Cancer Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Breast Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Breast Cancer Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Breast Cancer Drugs Market Analysis and Outlook to 2022
-
7.1 Global Breast Cancer Drugs Consumption (2017-2022)
-
7.2 United States Breast Cancer Drugs Consumption (2017-2022)
-
7.3 Europe Breast Cancer Drugs Consumption (2017-2022)
-
7.4 China Breast Cancer Drugs Consumption (2017-2022)
-
7.5 Japan Breast Cancer Drugs Consumption (2017-2022)
-
7.6 India Breast Cancer Drugs Consumption (2017-2022)
-
7.7 South Korea Breast Cancer Drugs Consumption (2017-2022)
8 Region and Country-wise Breast Cancer Drugs Market Analysis and Outlook to 2028
-
8.1 Global Breast Cancer Drugs Consumption Forecast (2022-2028)
-
8.2 United States Breast Cancer Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Breast Cancer Drugs Consumption Forecast (2022-2028)
-
8.4 China Breast Cancer Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Breast Cancer Drugs Consumption Forecast (2022-2028)
-
8.6 India Breast Cancer Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Breast Cancer Drugs Consumption Forecast (2022-2028)
9 Global Breast Cancer Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Breast Cancer Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HER2 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Mitotic Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anti-Metabolites Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Aromatase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Breast Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Breast Cancer Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Breast Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global HER2 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Mitotic Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anti-Metabolites Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Aromatase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Breast Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Breast Cancer Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Breast Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Breast Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Breast Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Breast Cancer Drugs Market Competitive Analysis
-
14.1 Dr Reddy's Laboratories
-
14.1.1 Dr Reddy's Laboratories Company Details
-
14.1.2 Dr Reddy's Laboratories Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dr Reddy's Laboratories Breast Cancer Drugs Product and Service
-
14.2 Puma Biotech
-
14.2.1 Puma Biotech Company Details
-
14.2.2 Puma Biotech Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Puma Biotech Breast Cancer Drugs Product and Service
-
14.3 Celltrion Inc
-
14.3.1 Celltrion Inc Company Details
-
14.3.2 Celltrion Inc Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celltrion Inc Breast Cancer Drugs Product and Service
-
14.4 Mylan
-
14.4.1 Mylan Company Details
-
14.4.2 Mylan Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Mylan Breast Cancer Drugs Product and Service
-
14.5 Roche Group
-
14.5.1 Roche Group Company Details
-
14.5.2 Roche Group Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Group Breast Cancer Drugs Product and Service
-
14.6 Merck Sharp & Dohme Corp
-
14.6.1 Merck Sharp & Dohme Corp Company Details
-
14.6.2 Merck Sharp & Dohme Corp Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Sharp & Dohme Corp Breast Cancer Drugs Product and Service
-
14.7 Verzenio (Eli Lilly)
-
14.7.1 Verzenio (Eli Lilly) Company Details
-
14.7.2 Verzenio (Eli Lilly) Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Verzenio (Eli Lilly) Breast Cancer Drugs Product and Service
-
14.8 GlaxoSmithKline
-
14.8.1 GlaxoSmithKline Company Details
-
14.8.2 GlaxoSmithKline Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline Breast Cancer Drugs Product and Service
-
14.9 Biocon
-
14.9.1 Biocon Company Details
-
14.9.2 Biocon Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biocon Breast Cancer Drugs Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Breast Cancer Drugs Product and Service
-
14.11 Pfizer
-
14.11.1 Pfizer Company Details
-
14.11.2 Pfizer Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer Breast Cancer Drugs Product and Service
-
14.12 Bristol-Myers Squibb
-
14.12.1 Bristol-Myers Squibb Company Details
-
14.12.2 Bristol-Myers Squibb Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Bristol-Myers Squibb Breast Cancer Drugs Product and Service
-
14.13 AstraZeneca
-
14.13.1 AstraZeneca Company Details
-
14.13.2 AstraZeneca Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 AstraZeneca Breast Cancer Drugs Product and Service
-
14.14 HALAVEN (Eisai Inc)
-
14.14.1 HALAVEN (Eisai Inc) Company Details
-
14.14.2 HALAVEN (Eisai Inc) Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 HALAVEN (Eisai Inc) Breast Cancer Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Breast Cancer Drugs
-
Figure Breast Cancer Drugs Picture
-
Table Global Breast Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Breast Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Breast Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Breast Cancer Drugs Consumption by Country (2017-2022)
-
Figure United States Breast Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Breast Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Breast Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Breast Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Breast Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Breast Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Breast Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Breast Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Breast Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Breast Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Breast Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Breast Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HER2 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Mitotic Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Metabolites Consumption and Growth Rate (2017-2022)
-
Figure Global Aromatase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global HER2 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mitotic Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Metabolites Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aromatase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Breast Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Breast Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Breast Cancer Drugs Product and Service
-
Table Puma Biotech (Foundation Year, Company Profile and etc.)
-
Table Puma Biotech Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Puma Biotech Breast Cancer Drugs Product and Service
-
Table Celltrion Inc (Foundation Year, Company Profile and etc.)
-
Table Celltrion Inc Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Inc Breast Cancer Drugs Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Breast Cancer Drugs Product and Service
-
Table Roche Group (Foundation Year, Company Profile and etc.)
-
Table Roche Group Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Group Breast Cancer Drugs Product and Service
-
Table Merck Sharp & Dohme Corp (Foundation Year, Company Profile and etc.)
-
Table Merck Sharp & Dohme Corp Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sharp & Dohme Corp Breast Cancer Drugs Product and Service
-
Table Verzenio (Eli Lilly) (Foundation Year, Company Profile and etc.)
-
Table Verzenio (Eli Lilly) Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Verzenio (Eli Lilly) Breast Cancer Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Breast Cancer Drugs Product and Service
-
Table Biocon (Foundation Year, Company Profile and etc.)
-
Table Biocon Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Breast Cancer Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Breast Cancer Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Breast Cancer Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Breast Cancer Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Breast Cancer Drugs Product and Service
-
Table HALAVEN (Eisai Inc) (Foundation Year, Company Profile and etc.)
-
Table HALAVEN (Eisai Inc) Breast Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table HALAVEN (Eisai Inc) Breast Cancer Drugs Product and Service
-
